FAQs – NASDAQ (US) Website

FAQs

BeiGene Ltd. was incorporated in the Cayman Islands on October 28, 2010.
BeiGene has corporate offices in Cambridge, Mass., Beijing, and Basel.
BeiGene’s fiscal year end is December 31st.
Ernst & Young Hua Ming LLP is BeiGene’s independent registered public accounting firm.
BeiGene’s US legal counsel is Goodwin Procter LLP.
BeiGene’s American Depositary Shares are traded under the ticker symbol “BGNE” on The NASDAQ Global Select Market. BeiGene’s initial public offering was on February 3, 2016.
BeiGene’s American Depositary Shares are traded under the ticker symbol “BGNE” on The NASDAQ Global Select Market. BeiGene’s initial public offering was on February 3, 2016.
BeiGene does not pay cash dividends on its American Depositary Shares.
BeiGene's transfer agent/depositary bank is Citibank, N.A.
Please submit an inquiry via our contact form.